OSSIO Inc.’s Distribution Deal With OrthoPediatrics Corp. Brings Bio-Integrative, Metal-Free OSSIOfiber® Implants to U.S. Children’s Hospitals Nationwide
In striking an exclusive distribution agreement with OrthoPediatrics Corp. announced today, OSSIO Inc. expands access to its revolutionary orthopedic fixation technology — bio-integrative, metal-free OSSIOfiber® implants — to the approximately 400 U.S. children’s hospitals and care facilities whose orthopedic surgeons treat most pediatric patients admitted with bone fractures and skeletal deformities.
Orthopedic Medical Technology Company Celebrates Grand Opening of U.S. Headquarters With Business, Government and Healthcare Leaders
OSSIO Inc., a fast-growing medical technology company focused on advancing orthopedic surgery with bio-integrative, metal-free fixation implants, celebrated the grand opening of its new U.S. headquarters in Manatee County’s City of Palmetto yesterday with Florida’s lieutenant governor and more than 50 other business, government and healthcare leaders.
Fast-Growing Orthopedics Company OSSIO Selects Florida for U.S. Headquarters and About 100 New Jobs
OSSIO Inc., a fast-growing medical technology company focused on evolving orthopedic surgery with bio-integrative, metal-free fixation implants, has selected Florida — specifically, the City of Palmetto in Manatee County, near Tampa — as the location of its new U.S headquarters, a move that is expected to create about 100 new jobs over the next five years.
OSSIO Launches Small OSSIOfiber® Suture Anchors, Expanding Best-in-Class Portfolio of Bio-Integrative, Metal-Free Implants to Improve Soft Tissue Fixation
OSSIO Inc., a fast-growing medical technology company focused on evolving orthopedic surgery with bio-integrative, metal-free implants, recently expanded its best-in-class soft-tissue fixation portfolio with the launch of OSSIOfiber® 2.5mm Suture Anchors, which promise to improve several surgical procedures, including Brostrom repair for lateral ankle instability.
